Asensus Surgical Analysis
Asensus Surgical is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Asensus Surgical delisted stock analysis is to determine its intrinsic value, which is an estimate of what Asensus Surgical is worth, separate from its market price. There are two main types of Asensus Surgical's stock analysis: fundamental analysis and technical analysis.
The Asensus Surgical stock is traded in the USA on NYSE MKT Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Asensus Surgical's ongoing operational relationships across important fundamental and technical indicators.
Asensus |
Asensus Stock Analysis Notes
About 18.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.31. Asensus Surgical last dividend was issued on the 12th of December 2019. The entity had 1:13 split on the 12th of December 2019. Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery in the United States, Europe, and Asia. Asensus Surgical, Inc. was founded in 2006 and is headquartered in Durham, North Carolina. Asensus Surgical operates under Medical Devices classification in the United States and is traded on AMEX Exchange. It employs 153 people. For more info on Asensus Surgical please contact Anthony Fernando at 919 765 8400 or go to https://www.asensus.com.Asensus Surgical Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Asensus Surgical's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Asensus Surgical or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Asensus Surgical is not yet fully synchronised with the market data | |
| Asensus Surgical has some characteristics of a very speculative penny stock | |
| Asensus Surgical has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 8.58 M. Net Loss for the year was (78.43 M) with loss before overhead, payroll, taxes, and interest of (3.79 M). | |
| Asensus Surgical currently holds about 94.2 M in cash with (63.63 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.4. |
Asensus Surgical Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Asensus Surgical previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 7th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 7th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Asensus Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 94.92 M.Asensus Surgical Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Asensus Surgical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Asensus Surgical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Asensus Surgical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Asensus Surgical Outstanding Bonds
Asensus Surgical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Asensus Surgical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Asensus bonds can be classified according to their maturity, which is the date when Asensus Surgical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US04364VAU70 Corp BondUS04364VAU70 | View | |
| Dana 575 percent Corp BondUS235822AB96 | View | |
| US04364VAR42 Corp BondUS04364VAR42 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
Asensus Surgical Technical and Predictive Indicators
| Risk Adjusted Performance | 0.0936 | |||
| Market Risk Adjusted Performance | (0.53) | |||
| Mean Deviation | 2.68 | |||
| Semi Deviation | 2.17 | |||
| Downside Deviation | 5.07 | |||
| Coefficient Of Variation | 851.84 | |||
| Standard Deviation | 6.26 | |||
| Variance | 39.19 | |||
| Information Ratio | 0.0975 | |||
| Jensen Alpha | 0.8779 | |||
| Total Risk Alpha | (0.27) | |||
| Sortino Ratio | 0.1204 | |||
| Treynor Ratio | (0.54) | |||
| Maximum Drawdown | 55.98 | |||
| Value At Risk | (4.17) | |||
| Potential Upside | 4.35 | |||
| Downside Variance | 25.72 | |||
| Semi Variance | 4.69 | |||
| Expected Short fall | (7.53) | |||
| Skewness | 5.12 | |||
| Kurtosis | 34.61 |
| Risk Adjusted Performance | 0.0936 | |||
| Market Risk Adjusted Performance | (0.53) | |||
| Mean Deviation | 2.68 | |||
| Semi Deviation | 2.17 | |||
| Downside Deviation | 5.07 | |||
| Coefficient Of Variation | 851.84 | |||
| Standard Deviation | 6.26 | |||
| Variance | 39.19 | |||
| Information Ratio | 0.0975 | |||
| Jensen Alpha | 0.8779 | |||
| Total Risk Alpha | (0.27) | |||
| Sortino Ratio | 0.1204 | |||
| Treynor Ratio | (0.54) | |||
| Maximum Drawdown | 55.98 | |||
| Value At Risk | (4.17) | |||
| Potential Upside | 4.35 | |||
| Downside Variance | 25.72 | |||
| Semi Variance | 4.69 | |||
| Expected Short fall | (7.53) | |||
| Skewness | 5.12 | |||
| Kurtosis | 34.61 |
About Asensus Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Asensus Surgical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Asensus shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Asensus Surgical. By using and applying Asensus Stock analysis, traders can create a robust methodology for identifying Asensus entry and exit points for their positions.
Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery in the United States, Europe, and Asia. Asensus Surgical, Inc. was founded in 2006 and is headquartered in Durham, North Carolina. Asensus Surgical operates under Medical Devices classification in the United States and is traded on AMEX Exchange. It employs 153 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Asensus Surgical to your portfolios without increasing risk or reducing expected return.Did you try this?
Run ETFs Now
ETFsFind actively traded Exchange Traded Funds (ETF) from around the world |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Asensus Stock
If you are still planning to invest in Asensus Surgical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Asensus Surgical's history and understand the potential risks before investing.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |